Trials / Sponsors / Kathleen Dorritie
Kathleen Dorritie
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Mezigdomide Plus Ixazomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma Relapsed and Refractory Multiple Myeloma | Phase 1 / Phase 2 | 2023-10-02 |
| Terminated | Stem Cell Transplant in Patients With Severe Sickle Cell Disease Sickle Cell Disease | EARLY_Phase 1 | 2018-03-29 |